Differential Recognition of Preproteins by the Purified Cytosolic Domains of the Mitochondrial Import Receptors Tom20, Tom22, and Tom70*

(Received for publication, April 22, 1997, and in revised form, June 5, 1997)

Jan Brix , Klaus Dietmeier and Nikolaus Pfanner Dagger

From the Institut für Biochemie und Molekularbiologie, Universität Freiburg, Hermann-Herder-Straße 7, D-79104 Freiburg, Germany

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

The preprotein translocase of the outer mitochondrial membrane (Tom) is a multi-subunit complex required for specific recognition and membrane translocation of nuclear-encoded preproteins. We have expressed and purified the cytosolic domains of three postulated import receptors, Tom20, Tom22, and Tom70. Each receptor domain is able to bind mitochondrial preproteins but with different specificity. Tom20 binds both preproteins with N-terminal presequences and preproteins with internal targeting signals; the binding is enhanced by the addition of salt. Tom22 selectively recognizes presequence-carrying preproteins in a salt-sensitive manner. Tom70 preferentially binds preproteins with internal targeting information. A chemically synthesized presequence peptide competes with preproteins for binding to Tom20 and Tom22 but not to Tom70. We conclude that each of the three import receptors binds preproteins independently and by a different mechanism. Both Tom20 and Tom22 function as presequence receptors.


INTRODUCTION

Nuclear-encoded mitochondrial proteins are synthesized as preproteins in the cytosol. They are targeted to receptors on the mitochondrial surface and are subsequently translocated across the outer mitochondrial membrane by a general import pore (1-5). The import receptors and the general import pore assemble into a dynamic high molecular weight complex, termed the preprotein translocase of the outer mitochondrial membrane (Tom) (6). Nine Tom proteins have been identified to date. Five of them expose major portions on the cytosolic side of the outer membrane: Tom20-Tom22 and Tom70-Tom37 were suggested to function as heterodimeric import receptors for distinct classes of preproteins (see below) (7-10). Tom72 is homologous to Tom70, yet is expressed at a low level and does not play a significant role in mitochondrial biogenesis (11, 12). The other four Tom proteins are associated with the general import pore: Tom40 is thought to represent the pore-forming component (13, 14); Tom5 promotes preprotein entry into the pore (15); and Tom6 and Tom7 modulate the association of the import pore with the receptor subcomplexes (16, 17).

Protein import studies with isolated mitochondria indicated that Tom20-Tom22 functions as receptor for the typical mitochondrial preproteins that carry N-terminal cleavable targeting sequences, termed presequences, which form positively charged amphipathic alpha -helices (9, 18-22). Tom70-Tom37 was reported to be required for import of noncleavable preproteins, carrying (poorly characterized) targeting information in the mature protein but also for cleavable preproteins (8, 23-26). Little is known about the function and specificity of individual receptor proteins. Only the cytosolic domain of Tom70 has been purified so far and used for analyzing binding of preproteins. Schlossmann et al. (27) showed that the cytosolic domain of Tom70 was able to bind noncleavable preproteins but also to some cleavable ones. Schleiff et al. (28) expressed Tom20 as part of a fusion protein with glutathione S-transferase and reported the binding of various preproteins to the fusion protein but also a high degree of nonspecific binding to the beads used.

For this report, we expressed and purified the cytosolic domains of Tom20, Tom22, and Tom70 and directly compared the ability of the three receptors to bind preproteins. We observed that each receptor domain could recognize and bind mitochondrial preproteins independently and with a different specificity. Only with Tom20 and Tom22, a synthetic presequence peptide competed for the binding of preproteins. Our studies indicate that each of the receptors binds mitochondrial preproteins by a different mechanism and show that two distinct presequence receptors function on the mitochondrial surface.


MATERIALS AND METHODS

Construction and Expression of the Cytosolic Domains of Tom20, Tom22, and Tom70

(His)10-tagged cytosolic domains of Tom20, Tom22 and Tom70 were amplified using the polymerase chain reaction and Saccharomyces cerevisiae genomic DNA as template. To amplify yTOM20cd-His10 (N-terminal His10 tag), the primers 5'-TATCATATGGACTATCAAAGAAGAAATAGCCGCCAATTC-3' and 5'-TATGGATCCTCAGTCATCGATATCGTTAGCTTCAGC-3' were used. To amplify TOM70cd-His10 (N-terminal His10 tag), the primers 5'-GTCGACATATGCGAGGAAAAAAGAACACGATC-3' and 5'-GGATCCCTCGAGTTACATTAAACCCTGTTCGCG-3' were used. The polymerase chain reaction products were digested with NdeI and BamHI or XhoI and cloned into pET19b. To amplify yTOM22cd-His10 (C-terminal His10 tag), the primers 5'-TATCCATGGTCGAATTAACTGAAATTA-3' and 5'-TATGGATCCTTAATGATGATGATGATGATGATGATGATGGTGGTTTCCGGATTTTGTGAAAGC-3' were used. After digestion of the polymerase chain reaction product with NcoI and BamHI, it was cloned into pET19b. The correct sequences of the clones were confirmed by DNA sequencing.

Escherichia coli strain BL21(DE3) was transformed with the plasmids pET19b-yTom20cd-His10, pET19b-yTom22cd-His10, or pET19b-yTom70cd-His10. The cells were grown overnight in LBA medium (0.5% (w/v) Bacto-yeast extract, 1% (w/v) Bacto-peptone, 0.5% (w/v) NaCl, 100 mg/l ampicillin) at 35 °C. 10-ml cultures were diluted 200-fold into LBA medium and grown up to an A600 of 0.7 in a 2-liter fermenter at pH 7.0. Then isopropyl-beta -D(-)-thiogalactopyranoside was added to the culture to a final concentration of 2 mM. The culture was incubated for a further 5 h. Cells were harvested by centrifugation, resuspended in 50 ml of resuspension buffer (10 mM MOPS/KOH,1 pH 7.2) and aliquoted. After centrifugation and removal of the supernatant, the bacterial pellets were frozen in liquid nitrogen and stored at -80 °C.

Purification of the Cytosolic Domains by Ni-NTA Affinity Chromatography

The bacterial pellet was resuspended in binding buffer (5 mM imidazole, 500 mM NaCl, 20 mM Tris/HCl, pH 7.9, containing 2 mM phenylmethylsulfonyl fluoride) and sonified in a Branson sonifier at 50% duty and setting 5 with a microtip by 3 × 10 pulses of 1 s at 0 °C. The suspension was centrifuged at 16,000 × g and 2 °C. The supernatant was applied on 1-ml Mobicol columns (Mobitec) that had been loaded with 800 µl of Ni-NTA-agarose resin slurry (Qiagen) and equilibrated with binding buffer. After an immediate spin in a microcentrifuge, the columns were washed five times with 500 µl of washing buffer (80 mM imidazole, 500 mM NaCl, 20 mM Tris/HCl, pH 7.9). The protein-loaded resin was resuspended in washing buffer and aliquoted.

One aliquot was analyzed by SDS-PAGE to assay the purity and the amount of protein bound to the Ni-NTA-agarose. The identity of the purified proteins was confirmed by Western blotting with the corresponding antibodies.

Assay for Binding of Preproteins

The protein-loaded Ni-NTA resin (final amount of 50 pmol of each Tom protein/100-µl assay) was equilibrated with assay buffer (20 mM imidazole, 0-200 mM KCl, 10 mM MOPS/KOH, pH 7.2, 1% (w/v) BSA) by mixing, centrifugation, and discarding the supernatant (three times). The resuspended resin was divided into equal volumes and transferred into 1-ml Mobicol columns that were closed at the bottom side. A mixture of 35S-labeled preproteins in assay buffer (maximum 7% (v/v) rabbit reticulocyte lysate) was added, and the resin was resuspended by vortexing. Where indicated, the synthetic presequence peptide CoxIV(1-23) or the control peptide SynB2, which were blocked N-terminally by acetylation and C-terminally by amidation, were included (to avoid peptide dimers, the cysteine at position 19 of CoxIV(1-23) was replaced by a serine). The total volume of the reaction was 100 µl. The columns were incubated under mixing at 30 °C for 40 min in a thermomixer (Eppendorf, setting 11). After centrifugation, the resin was washed three times with the corresponding assay buffer without BSA. Finally all bound proteins were eluted with elution buffer (1 M imidazole, 500 mM NaCl, 20 mM Tris/HCl, pH 7.9) and precipitated by adding 12% (w/v) trichloroacetic acid. After 20 min of incubation at 0 °C, the proteins were sedimented by centrifugation (40,000 × g) and washed with acetone. The protein complexes were analyzed by SDS-PAGE and digital autoradiography (phosphor storage imaging technology; Molecular Dynamics).

Miscellaneous Procedures

The following procedures were carried out as described previously: synthesis of preproteins in rabbit reticulocyte lysate and labeling with [35S]methionine/[35S]cysteine (29, 30) and SDS-PAGE (31).


RESULTS

The Purified Domains of Tom20, Tom22, and Tom70 Selectively Bind Mitochondrial Preproteins

For expression of the cytosolic domains of S. cerevisiae Tom20, Tom22 and Tom70, the predicted single membrane anchor sequence of each protein was replaced by a His10 tag. Tom20 and Tom70 carry the membrane anchor at the N terminus and expose the C terminus on the cytosolic side (Fig. 1A) (19, 24, 25); therefore the His10 tag was placed at the N terminus of the cytosolic domains. Tom22 exposes the N terminus on the cytosolic side and contains a membrane anchor in the middle and a C-terminal segment on the intermembrane space side (32). The cytosolic domain of Tom22 was thus tagged with a C-terminal His10 tag. By use of the plasmid pET19 and induction by isopropyl-beta -D(-)-thiogalactopyranoside, the cytosolic domains were expressed in E. coli cells to ~1-5% of total cellular protein (Fig. 1B, lanes 2-4). The cytosolic domains were purified from the soluble fraction of the E. coli cells by Ni-NTA affinity chromatography. The proteins were more than 95% pure (Fig. 1C).


Fig. 1. Expression and purification of the cytosolic domains of Tom20, Tom22, and Tom70. A, predicted topology of Tom20, Tom22, and Tom70. C, C terminus; IMS, intermembrane space; N, N terminus; OM, outer mitochondrial membrane. B, expression in E. coli. Expression of the recombinant cytosolic domains, residues 30-183 of Tom20, residues 1-97 of Tom22, and residues 38-617 of Tom70 (each containing a His10 tag instead of the predicted membrane anchor), was induced by isopropyl-beta -D(-)-thiogalactopyranoside as described under "Materials and Methods." The cells were lysed by freeze-thawing and sonication. An aliquot of the supernatant was separated by SDS-PAGE and stained by Coommassie Brilliant Blue R250. The protein pattern of a noninduced strain is shown in lane 1. M, molecular mass markers. The bands of Tom20cd, Tom22cd, and Tom70cd are marked with arrowheads in lanes 2, 3, and 4, respectively. C, purified cytosolic domains. The recombinant proteins were purified by Ni-NTA chromatography. The eluate was analyzed by SDS-PAGE and stained with Coommassie Brilliant Blue R250. The electrophoretic mobility of Tom20cd and Tom22cd was slower than predicted from the primary structure.
[View Larger Version of this Image (38K GIF file)]

Equimolar amounts of the cytosolic domains of Tom20, Tom22, and Tom70 bound to the Ni-NTA resin were used for binding assays with mitochondrial preproteins (Fig. 2, lanes 1-3). The control sample contained Ni-NTA resin that was subjected to a mock treatment with lysates from noninduced E. coli cells (Fig. 2, lane 4). The following preproteins were synthesized in rabbit reticulocyte lysates in the presence of [35S]methionine/[35S]cysteine: a fusion protein between the presequence of Fo-ATPase subunit 9 and entire dihydrofolate reductase (Su9-DHFR) (33); as control, the DHFR (a cytosolic enzyme) alone; a fusion protein containing the presequence plus 87 N-terminal amino acid residues of mature cytochrome b2 and the DHFR (b2Delta -DHFR; a 19-residue hydrophobic sorting segment of the 80-residue presequence was deleted) (34); the authentic precursor of cytochrome c1 that includes an N-terminal presequence with a hydrophobic sorting signal and a membrane anchor segment in the mature protein part; the phosphate carrier (PiC) that is synthesized without a presequence but contains internal targeting and membrane anchor sequences. The labeled preproteins were incubated with the resin-bound cytosolic domains at 30 °C under continuous mixing. After washing, bound proteins were eluted and analyzed by SDS-PAGE and digital autoradiography (Fig. 2).


Fig. 2. Differential binding of mitochondrial preproteins to purified receptor domains. Equimolar amounts of the recombinant His-tagged cytosolic domains of Tom20, Tom22, and Tom70 were bound to Ni-NTA columns. For the control, the lysate of the E. coli host strain was subjected to a mock treatment including incubation with Ni-NTA. Then an incubation with 35S-labeled preproteins in assay buffer (with 100 mM KCl) was performed at 30 °C for 40 min as described under "Materials and Methods." After removal of excess BSA from the columns, the bound protein complexes were eluted and analyzed by SDS-PAGE. Standard (STD) was 5% of labeled preprotein mix that was added to the Ni-NTA columns. Quantification was done by digital autoradiography. The total amount of each preprotein added was set to 100%, respectively. Cyt. c1, cytochrome c1.
[View Larger Version of this Image (21K GIF file)]

Each of the cytosolic domains interacted with a distinct subset of the proteins added. Tom20cd bound all four mitochondrial preproteins (Fig. 2, lane 1). Tom22cd bound preferentially b2Delta -DHFR and cytochrome c1 and bound only very weakly Su9-DHFR (Fig. 2, lane 2), whereas binding of PiC was in the background range (Fig. 2, lanes 2 and 4). Tom70cd bound cytochrome c1 and PiC but not the DHFR fusion proteins (Fig. 2, lane 3). DHFR alone did not bind to any of the three cytosolic domains (Fig. 2). To minimize unspecific binding of preproteins to the resin-bound cytosolic domains, we included a 300-fold molar excess of BSA (over the purified cytosolic domains) in the binding assays; however, the omission of BSA did not affect the efficiency and selectivity of preprotein binding (not shown). We conclude that the cytosolic domains of Tom20, Tom22, and Tom70 selectively bind distinct subsets of mitochondrial preproteins.

Differential Effect of Salt on Preprotein Binding to Tom22 and Tom20

The cytosolic domain of Tom22 contains a large number of negatively charged amino acid residues and was suggested to interact with the positively charged amphipathic presequences (7, 9, 10, 32). We thus wondered why Su9-DHFR bound to Tom22cd only with such a low efficiency. The binding assays reported in Fig. 2 were performed in the presence of 100 mM KCl that could interfere with a possible ionic interaction between the charged residues of presequences and Tom22. At low salt, the binding of Su9-DHFR to Tom22cd was indeed strongly enhanced (Fig. 3). Also the binding of b2Delta -DHFR to Tom22cd was increased at low salt, whereas that of cytochrome c1 was largely salt-insensitive, and PiC did not bind to Tom22cd at any salt concentration tested (Fig. 3).


Fig. 3. Binding of preproteins to the cytosolic domain of Tom22 is salt-sensitive. The binding assay and the quantification were performed as described in the legend of Fig. 2 except that the concentration of KCl was varied from 0 to 200 mM.
[View Larger Version of this Image (45K GIF file)]

Tom20 contains a segment with negatively charged residues and was similarly suggested to bind preproteins by ionic interactions (7, 10, 21, 35). We asked if lowering of the salt concentration enhanced preprotein binding to Tom20cd. Surprisingly, the binding of Su9-DHFR and b2Delta -DHFR as well as that of cytochrome c1 and PiC to Tom20cd were inhibited at low salt (Fig. 4, lane 1). An increase in the concentration of KCl to 200 mM even enhanced binding of all four preproteins to Tom20cd (Fig. 4, lane 3), whereas DHFR did not bind at any salt concentration tested (Fig. 4, lanes 1-3). The binding of preproteins to Tom20cd and Tom22cd therefore reveals an opposite dependence on the salt concentration (Fig. 4, lanes 1-3 versus 4-6).


Fig. 4. Binding of preproteins to Tom20 is stimulated by addition of salt, whereas binding to Tom70 is not influenced by salt. The experiments were performed as described in the legend of Fig. 2 except that KCl was added to a final concentration of 0, 120, or 200 mM, respectively.
[View Larger Version of this Image (38K GIF file)]

Binding of cytochrome c1 and PiC to Tom70cd, however, were only slightly influenced by a variation of the KCl concentration from 0-200 mM (Fig. 4, lanes 7-9). Moreover, Su9-DHFR and b2Delta -DHFR did not bind to Tom70cd at any salt concentration.

We conclude that binding of preproteins to Tom20cd is stimulated by salt, whereas the binding of preproteins to Tom22cd is inhibited by salt. Binding of preproteins to Tom70cd is salt-insensitive. Only Tom20cd is able to bind significant amounts of all four mitochondrial preproteins tested.

A Chemically Synthesized Presequence Peptide Competes with Binding of Preproteins to Tom22 and Tom20

To further determine the specificity of preprotein binding to the cytosolic domains, we used two chemically synthesized peptides (Fig. 5A). The 23 N-terminal residues of the 25-residue presequence of subunit IV of cytochrome c oxidase (CoxIV) function as a mitochondrial import signal; they can form an amphipathic alpha -helix with a positively charged side and a hydrophobic side (36-39). The peptide SynB2 contains the same number of positively charged residues but lacks the hydrophobic site and does not function as mitochondrial import signal (36).


Fig. 5. A synthetic presequence peptide competes with binding of preproteins to the cytosolic domain of Tom22. A, synthetic presequence peptide CoxIV(1-23) and control peptide SynB2. Both peptides are blocked N- and C-terminally. B and C, binding of preproteins to Tom22cd was performed as described in the legend of Fig. 2 except that no KCl was added and the peptides CoxIV(1-23) or SynB2 were present at the indicated concentrations.
[View Larger Version of this Image (42K GIF file)]

Binding of preproteins to Tom22cd was performed in the presence of different concentrations of the presequence peptide or the control peptide. The presequence peptide strongly inhibited the binding of Su9-DHFR and b2Delta -DHFR (Fig. 5B, lanes 2-7). Half-maximal inhibition of preprotein binding occurred at ~6 µM peptide in the case of Su9-DHFR and at ~10 µM peptide in the case of b2Delta -DHFR (Fig. 5C). In concentrations up to 20 µM, the peptide SynB2 revealed only a slight inhibitory effect on binding of these two preproteins to Tom22cd (Fig. 5, B, lanes 8 and 9, and C); at 30 µM, it caused a partial inhibition of binding (Fig. 5, B, lane 10, and C). The inhibitory effect of the presequence peptide on binding of cytochrome c1 to Tom22cd was not as strong as that on the binding of the two DHFR fusion proteins but still significantly distinct from that of the peptide SynB2 (Fig. 5, B and C).

Binding of the preproteins cytochrome c1 and PiC to Tom70cd was inhibited neither by the presequence peptide (Fig. 6, A and B) nor by the peptide SynB2 (not shown), independently of the salt concentration in the assay.


Fig. 6. The presequence peptide does not influence preprotein binding to Tom70cd. Preprotein binding in the presence of the presequence peptide (CoxIV(1-23)) (A) and quantification (B) were performed as described in the legends of Figs. 2 and 5 except that the cytosolic domain of Tom70 was used and KCl was present at the indicated concentrations.
[View Larger Version of this Image (25K GIF file)]

With Tom20cd the presequence peptide competed with the binding of all three presequence-containing preproteins, b2Delta -DHFR, cytochrome c1, and Su9-DHFR (Fig. 7A) in contrast to the control peptide SynB2 (Fig. 7B). The half-maximal inhibition of binding was obtained at a concentration of the presequence peptide of ~4 µM in the case of Su9-DHFR (Fig. 7A, lanes 13-27, and C) and ~10 µM in the case of b2Delta -DHFR (Fig. 7C). In the case of cytochrome c1, inhibition was weaker (Fig. 7, A and C). Binding of the noncleavable preprotein PiC to Tom20cd, however, was not competed for by the presequence peptide (Fig. 7, A and C).


Fig. 7. The presequence peptide competes with binding of cleavable preproteins to Tom20cd. The binding of preproteins (A and B) and quantification (C) were performed as described in the legends of Figs. 2 and 5 with the following modifications. Tom20cd was used. The peptides CoxIV(1-23) (A and C) and SynB2 (B and C) were included at the indicated concentrations. The concentration of KCl in the assay is indicated.
[View Larger Version of this Image (31K GIF file)]

We conclude that a chemically synthesized presequence peptide competes with the binding of cleavable preproteins to Tom20cd and Tom22cd. Binding of preproteins to Tom70cd is not affected by the presequence peptide.


DISCUSSION

We report that the purified cytosolic domains of yeast Tom20, Tom22, and Tom70 selectively bind distinct subsets of mitochondrial preproteins. The overall pattern of preprotein binding to the recombinant domains agrees well with the preprotein specificities that have been predicted for these Tom proteins by studying their function with mitochondria or outer membrane vesicles (summarized in Refs. 1, 3, and 40). Together with the lack of binding of a nonmitochondrial protein and the competition by a synthetic presequence peptide, this underscores the validity of the in vitro binding assays presented here.

The analysis in the purified system provides several new insights in the mechanism of action of mitochondrial import receptors. First, each cytosolic domain alone can specifically bind preproteins without a requirement for other Tom proteins. Second, the characteristics of binding of the same preprotein are different for each of the cytosolic domains, suggesting different functional mechanisms for the three import receptors. Although it has been expected that Tom70, which preferentially binds preproteins with internal targeting information (23-27), functions differently than Tom20 and Tom22, the latter two receptors were assumed to bind preproteins by a similar mechanism. Both were suggested to bind positively charged presequences in a salt-sensitive (ionic) manner (7, 9, 10, 21, 35). Moreover, Mayer et al. (10) proposed that Tom20 and Tom22 do not constitute independent binding sites for preproteins but function as a single heterodimeric receptor.

The findings reported here suggest the following characteristics of mitochondrial import receptors. (i) Tom22: Binding to Tom22cd requires the presence of a cleavable presequence. Binding of a preprotein, which consists only of an amphipathic mitochondrial presequence and a cytosolic passenger protein, is highly sensitive to the addition of salt and is strongly competed for by a synthetic presequence peptide. This suggests that binding occurs solely via the presequence and that the positively charged surface of the presequence interacts with the highly negatively charged Tom22cd (32) in a ionic manner. (ii) Tom20: Cleavable and noncleavable preproteins bind to yeast Tom20cd, indicating a broad substrate specificity for this import receptor in agreement with the binding properties of a fusion protein between glutathione S-transferase and human Tom20 (28). The binding of preproteins to yeast Tom20cd is stimulated by the addition of salt, leading to the unexpected conclusion that preprotein recognition by Tom20cd is not mediated by ionic forces but probably by a hydrophobic type of interaction. Tom20cd probably interacts with the hydrophobic surface of the amphipathic presequences. Interestingly, a higher concentration of a control peptide, which contains the same number of positive charges as the presequence peptide but lacks the hydrophobic character partially inhibits preprotein binding to Tom22cd but not to Tom20cd. The opposite influence of salt supports the view that Tom22cd and Tom20cd recognize distinct surfaces of a presequence. It has been shown that synthetic presequences form amphipathic alpha -helices at amphiphilic surfaces such as detergent micelles or lipid bilayers but not in water (37-39), suggesting that the interaction of presequences with the binding site/cleft of a receptor may induce the formation of an alpha -helical structure. Because a synthetic presequence peptide competes with the binding of cleavable preproteins but not with that of a noncleavable one to Tom20cd, it is likely that Tom20 employs distinct mechanisms for recognition of presequences and internal targeting sequences. (iii) Tom70: Binding of preproteins to Tom70cd is largely insensitive to the presence or the absence of salt and is not competed for by the presequence peptide, clearly distinguishing the binding properties from that of Tom22cd and Tom20cd. Tom70cd apparently does not recognize mitochondrial presequences but targeting information contained in the mature part of preproteins.

The cleavable preprotein cytochrome c1 behaves differently than other cleavable preproteins because it does not only bind to Tom20cd and Tom22cd but also to Tom70cd. This broad receptor dependence of cytochrome c1 is in agreement with import studies of this preprotein into mitochondria (26, 41). Moreover, the binding to Tom20cd and Tom22cd is only partially competed for by the synthetic presequence peptide, and the binding to Tom22cd is only slightly inhibited by increasing the salt concentration. This suggests that cytochrome c1 may not only carry targeting information within the amphipathic part of the presequence but also in additional protein parts. Although further work is needed to identify putative internal targeting signals of cytochrome c1, previous studies on the import of chimeric preproteins into mitochondria indeed suggested that some cleavable preproteins carry targeting information not only in the presequence but also within the mature protein (42-44).

The binding characteristics observed with different preproteins raise the speculation that Tom20cd as well as Tom22cd may contain more than a single binding site for preproteins each. (i) The major binding site of Tom22cd is obviously that for the positively charged surface of presequences. In addition, internal targeting information of a preprotein can stabilize the binding (cytochrome c1) but is not sufficient to promote binding by itself (PiC). A putative second binding site on Tom22cd would thus not function independently but would play an auxiliary role. (ii) Tom20cd may contain two binding sites, one for the hydrophobic surface of presequences and one for internal targeting information, each of which is apparently competent for recognition of preproteins. (iii) Tom70cd contains a binding site for internal targeting information that is not influenced by presequences.

Irrespective of these speculations, it is evident that each of the three import receptors Tom20, Tom22, and Tom70 can bind mitochondrial preproteins independently of other Tom proteins. In particular, this demonstrates that two presequence receptors operate at the mitochondrial outer membrane. The concentration of presequence peptide needed for half-maximal competition of binding (4-10 µM) suggests a relatively low affinity for the import receptors. The presence of two presequence receptors that recognize distinct properties of the same presequence should thus strongly enhance the specificity and fidelity of preprotein recognition at the mitochondrial surface.


FOOTNOTES

*   This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 388, and the Fonds der Chemischen Industrie.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed. Tel.: 49-761-203-5224; Fax: 49-761-203-5261; E-mail: pfanner{at}ruf.uni-freiburg.de.
1   The abbreviations used are: MOPS, 4-morpholinepropanesulfonic acid; DHFR, dihydrofolate reductase; PiC, phosphate carrier; Ni-NTA, nickel nitrilotriacetate; PAGE, polyacrylamide gel electrophoresis; BSA, bovine serum albumin.

ACKNOWLEDGEMENTS

We thank Dr. Bernard Guiard for plasmids and Dr. Michael Ryan for critical comments on the manuscript.


REFERENCES

  1. Kübrich, M., Dietmeier, K., and Pfanner, N. (1995) Curr. Genet. 27, 393-403 [Medline] [Order article via Infotrieve]
  2. Ryan, K. R., and Jensen, R. E. (1995) Cell 83, 517-519 [Medline] [Order article via Infotrieve]
  3. Lill, R., and Neupert, W. (1996) Trends Cell. Biol. 6, 56-61 [CrossRef]
  4. Schatz, G., and Dobberstein, B. (1996) Science 271, 1519-1526 [Abstract]
  5. Pfanner, N., and Meijer, M. (1997) Curr. Biol. 7, R100-R103 [Medline] [Order article via Infotrieve]
  6. Pfanner, N., Douglas, M. G., Endo, T., Hoogenraad, N. J., Jensen, R. E., Meijer, M., Neupert, W., Schatz, G., Schmitz, U. K., and Shore, G. C. (1996) Trends Biochem. Sci. 21, 51-52 [CrossRef][Medline] [Order article via Infotrieve]
  7. Bolliger, L., Junne, T., Schatz, G., and Lithgow, T. (1995) EMBO J. 14, 6318-6326 [Abstract]
  8. Gratzer, S., Lithgow, T., Bauer, R. E., Lamping, E., Paltauf, F., Kohlwein, S. D., Haucke, V., Junne, T., Schatz, G., and Horst, M. (1995) J. Cell. Biol. 129, 25-34 [Abstract]
  9. Hönlinger, A., Kübrich, M., Moczko, M., Gärtner, F., Mallet, L., Bussereau, F., Eckerskorn, C., Lottspeich, F., Dietmeier, K., Jacquet, M., and Pfanner, N. (1995) Mol. Cell. Biol. 15, 3382-3389 [Abstract]
  10. Mayer, A., Nargang, F. E., Neupert, W., and Lill, R. (1995) EMBO J. 14, 4204-4211 [Abstract]
  11. Bömer, U., Pfanner, N., and Dietmeier, K. (1996) FEBS Lett. 382, 153-158 [CrossRef][Medline] [Order article via Infotrieve]
  12. Schlossmann, J., Lill, R., Neupert, W., and Court, D. A. (1996) J. Biol. Chem. 271, 17890-17895 [Abstract/Free Full Text]
  13. Vestweber, D., Brunner, J., Baker, A., and Schatz, G. (1989) Nature 341, 205-209 [CrossRef][Medline] [Order article via Infotrieve]
  14. Kiebler, M., Pfaller, R., Söllner, T., Griffiths, G., Horstmann, H., Pfanner, N., and Neupert, W. (1990) Nature 348, 610-616 [CrossRef][Medline] [Order article via Infotrieve]
  15. Dietmeier, K., Hönlinger, A., Bömer, U., Dekker, P. J. T., Eckerskorn, C., Lottspeich, F., Kübrich, M., and Pfanner, N. (1997) Nature, in press
  16. Alconada, A., Kübrich, M., Moczko, M., Hönlinger, A., and Pfanner, N. (1995) Mol. Cell. Biol. 15, 6196-6205 [Abstract]
  17. Hönlinger, A., Bömer, U., Alconada, A., Eckerskorn, C., Lottspeich, F., Dietmeier, K., and Pfanner, N. (1996) EMBO J. 15, 2125-2137 [Abstract]
  18. Söllner, T., Griffiths, G., Pfaller, R., Pfanner, N., and Neupert, W. (1989) Cell 59, 1061-1070 [Medline] [Order article via Infotrieve]
  19. Schneider, H., Söllner, T., Dietmeier, K., Eckerskorn, C., Lottspeich, F., Trülzsch, B., Neupert, W., and Pfanner, N. (1991) Science 254, 1659-1662 [Medline] [Order article via Infotrieve]
  20. Ramage, L., Junne, T., Hahne, K., Lithgow, T., and Schatz, G. (1993) EMBO J. 12, 4115-4123 [Abstract]
  21. Moczko, M., Ehmann, B., Gärtner, F., Hönlinger, A., Schäfer, E., and Pfanner, N. (1994) J. Biol. Chem. 269, 9045-9051 [Abstract/Free Full Text]
  22. Lithgow, T., Junne, T., Suda, K., Gratzer, S., and Schatz, G. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11973-11977 [Abstract/Free Full Text]
  23. Söllner, T., Pfaller, R., Griffiths, G., Pfanner, N., and Neupert, W. (1990) Cell 62, 107-115 [Medline] [Order article via Infotrieve]
  24. Steger, H. F., Söllner, T., Kiebler, M., Dietmeier, K. A., Pfaller, R., Trülzsch, K. S., Tropschug, M., Neupert, W., and Pfanner, N. (1990) J. Cell. Biol. 111, 2353-2363 [Abstract]
  25. Hines, V., Brandt, A., Griffiths, G., Horstmann, H., Brütsch, H., and Schatz, G. (1990) EMBO J. 9, 3191-3200 [Abstract]
  26. Hines, V., and Schatz, G. (1993) J. Biol. Chem. 268, 449-454 [Abstract/Free Full Text]
  27. Schlossmann, J., Dietmeier, K., Pfanner, N., and Neupert, W. (1994) J. Biol. Chem. 269, 11893-11901 [Abstract/Free Full Text]
  28. Schleiff, E., Shore, G. C., and Goping, I. S. (1997) FEBS Lett. 404, 314-318 [CrossRef][Medline] [Order article via Infotrieve]
  29. Pelham, H. R. B., and Jackson, R. J. (1976) Eur. J. Biochem. 67, 247-256 [Abstract]
  30. Alconada, A., Gärtner, F., Hönlinger, A., Kübrich, M., and Pfanner, N. (1995) Methods Enzymol. 260, 263-286 [Medline] [Order article via Infotrieve]
  31. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  32. Kiebler, M., Keil, P., Schneider, H., van der Klei, I. J., Pfanner, N., and Neupert, W. (1993) Cell 74, 483-492 [Medline] [Order article via Infotrieve]
  33. Pfanner, N., Tropschug, M., and Neupert, W. (1987) Cell 49, 815-823 [Medline] [Order article via Infotrieve]
  34. Koll, H., Guiard, B., Rassow, J., Ostermann, J., Horwich, A. L., Neupert, W., and Hartl, F. U. (1992) Cell 68, 1163-1175 [Medline] [Order article via Infotrieve]
  35. Haucke, V., Lithgow, T., Rospert, S., Hahne, K., and Schatz, G. (1995) J. Biol. Chem. 270, 5565-5570 [Abstract/Free Full Text]
  36. Allison, D. S., and Schatz, G. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 9011-9015 [Abstract]
  37. Roise, D., Horvath, S. J., Tomich, J. M., Richards, J. H., and Schatz, G. (1986) EMBO J. 5, 1327-1334 [Abstract]
  38. Roise, D., Theiler, F., Horvath, S. J., Tomich, J. M., Richards, J. H., Allison, D. S., and Schatz, G. (1988) EMBO J. 7, 649-653 [Abstract]
  39. Tamm, L. K., and Bartoldus, I. (1990) FEBS Lett. 272, 29-33 [CrossRef][Medline] [Order article via Infotrieve]
  40. Lithgow, T., Glick, B. S., and Schatz, G. (1995) Trends Biochem. Sci. 20, 98-101 [CrossRef][Medline] [Order article via Infotrieve]
  41. Hönlinger, A., Keil, P., Nelson, R. J., Craig, E. A., and Pfanner, N. (1995) Biol. Chem. 376, 515-519
  42. Bedwell, D. M., Klionsky, D. J., and Emr, S. D. (1987) Mol. Cell. Biol. 7, 4038-4047 [Medline] [Order article via Infotrieve]
  43. Pfanner, N., Müller, H. K., Harmey, M. A., and Neupert, W. (1987) EMBO J. 6, 3449-3454 [Abstract]
  44. Zara, V., Palmieri, F., Mahlke, K., and Pfanner, N. (1992) J. Biol. Chem. 267, 12077-12081 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.